Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies

⟵ Back to Search Results

Beigene Study ID

BGB-3111-113

ClinicalTrials.gov ID

NCT04551963

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents

Sex: All

Age: 18 Years and older (Adult, Older Adult)

No Study Documents